Abstract
The synthesis, in vitro anti-HIV activity, and preliminary stability studies of several mononucleoside phosphorodithiolate derivatives incorporating a new kind of bio-labile phosphate-protection, namely 0-pivaloyl-2-oxyethyl, are reported. Our preliminary results strongly support the hypothesis that such pronucleotides exert their biological effects via intracellular delivery of the corresponding 5′-mononucleotide.